A case report of a therapeutic drug monitoring-guided sofosbuvir-velpatasvir crushed treatment
S. Lalanne
,
C. Tron
,
M. C. Verdier
,
C. Jezequel
,
M. Mercerolle
et al.
Fundamental & Clinical Pharmacology , 2021, 35, pp.182-183
Journal articles
hal-03329976v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
High intrapatient variability of tacrolimus exposure is associated with poorer outcomes after liver transplantation
Camille Tron
,
M. Rayar
,
C. Jezequel
,
A. Petitcollin
,
P. Houssel-Debry
et al.
15th International congress of Therapeutic Drug Monitoring and Clinical Toxicology , Sep 2017, Kyoto, Japan
Conference papers
hal-02463139v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Managing Drug-Drug Interaction between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Mycophenolate Mofetil
F. Lemaitre
,
Z. Ben Ali
,
C. Tron
,
C. Jezequel
,
C. Boglione-Kerrien
et al.
Journal articles
hal-01614699v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
P0709 : Survival of patients infected by chronic hepatitis c and f0f1 fibrosis at baseline after a 15 years follow-up
C. Jezequel
,
Edouard Bardou-Jacquet
,
Y. Desille
,
I. Renard
,
F. Lainé
et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver , Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S589, 2015,
⟨10.1016/S0168-8278(15)30912-0⟩
Conference poster
hal-01162776v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation A retrospective cohort study
A. Huguet
,
M. Latournerie
,
P.H. Debry
,
C. Jezequel
,
L. Legros
et al.
Journal articles
hal-01777713v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Managing drug-drug interaction between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir and Mycophenolate mofetil
C. Tron
,
F. Lemaître
,
Z. Ben Ali
,
C. Leven
,
C. Jezequel
et al.
Fundamental & Clinical Pharmacology , 2016, 30, pp.85--85
Journal articles
hal-01310757v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Redefining therapeutic drug monitoring of tacrolimus in liver transplantation: can we target trough concentrations below 7 ng/ml during the first month?
F. Lemaitre
,
C. Tron
,
C. Jezequel
,
S. Lalanne
,
M. C. Verdier
et al.
Fundamental & Clinical Pharmacology , 2021, 35, pp.82-82
Journal articles
hal-03329940v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Deciphering pharmacogenetic-whole blood/intracellular pharmacokinetic-pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients
C. Tron
,
J. B. Woillard
,
P. Houssel-Debry
,
V. David
,
M. Rayar
et al.
Fundamental & Clinical Pharmacology , 2021, 35, pp.168-168
Journal articles
hal-03329966v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
O095 : High transferrin saturation during maintenance venesection therapy in HFE hemochromatosis is associated with increased morbidity regardless of serum ferritin levels
Edouard Bardou-Jacquet
,
C. Jezequel
,
J. Morcet
,
F. Lainé
,
D. Guyader
et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver , Apr 2015, Vienne, Austria. pp.S242,
⟨10.1016/S0168-8278(15)30114-8⟩
Conference papers
hal-01162708v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Baseline serum ferritin is an independent predictive factor of mortality in patients with chronic hepatitis C after long term follow-up
C. Jezequel
,
Z. B. Ali
,
C. Pronier
,
A. Rabot
,
I. Renard
et al.
Journal articles
hal-01559891v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study
P. Houssel-Debry
,
C. Duvoux
,
A. Coilly
,
C. Fougerou-Leurent
,
C. Jezequel
et al.
Journal articles
hal-01533345v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More